Oxotremorine (sesquifumarate)


CAS No. : 17360-35-9

17360-35-9
Price and Availability of CAS No. : 17360-35-9
Size Price Stock
5mg $72 In-stock
10mg $115 In-stock
25mg $230 In-stock
50 mg Get quote
100 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-101239
M.Wt: 380.38
Formula: C12H18N2O.3/2C4H4O4
Purity: >98 %
Solubility: H2O : 100 mg/mL (ultrasonic);DMSO : 125 mg/mL (ultrasonic)
Introduction of 17360-35-9 :

Oxotremorine sesquifumarate is a potent muscarinic acetylcholine receptor (mAChR) agonist capable of crossing the blood-brain barrier. Oxotremorine sesquifumarate specifically binds to and activates mAChR, mediating synaptic transmission, influencing the survival and differentiation of nerve cells, and inducing symptoms associated with cholinergic overactivation in animals. Oxotremorine sesquifumarate can be used as a pharmacological agent to induce symptoms such as tremors, hypothermia, and salivation in experimental animals. Oxotremorine sesquifumarate is utilized in research on neurological disorders, including Parkinson’s disease and depression[1][2][3][4][5][6][7][8][9][10][11][12][13]. In Vivo:Oxotremorine (10-100 μg/kg; i.p.; single dose; tested 30 min post-injection) sesquifumarate exhibits antinociceptive effects in the tail-flick test, hot-plate test, and a formalin-induced pain model in naked mole-rats[3].
Oxotremorine (0.2 mg/kg; i.p.; once daily; for 10 consecutive days) sesquifumarate restores impaired hippocampal neurogenesis, mitigates depression-like behaviors, and recovers hippocampal volume in a rat model of chronic restraint stress[5].
Oxotremorine sesquifumarate (1.0-10.0 μg/side; bilateral microinjection into the nucleus accumbens; single administration; 2 h) reduces food and water intake and decreases locomotor activity in food-deprived Sprague-Dawley rats[11].

Note:
Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.

Induction of tremor and lacrimation model[4][11]
Background
Oxotremorine sesquifumarate produces potent parasympathomimetic and central effects by non-selectively activating central and peripheral muscarinic acetylcholine receptors[4].
Specific Modeling Methods
Mice: male albino mice (Haffkine strain)
Administration: Oxotremorine (0.5 mg/kg) sesquifumarate • single intraperitoneal injection
Mice: male ICR mice • 25-35 g
Administration: (1) Oxotremorine sesquifumarate (0.5 mg/kg) • Single subcutaneous (s.c.) injection; (2) 0.5 mg/kg • Single subcutaneous (s.c.) injection, following a 20-minute pretreatment with Phenylephrine (10 µg/kg; i.p.)
Note
(1) Since the onset of tremors following drug administration is almost immediate, the recording of tremors must begin immediately after the drug is administered.
(2) Behavioral assessments, such as the evaluation of tremors, must be conducted while the animals are in a conscious state.
Modeling Indicators
Animal Behavior Analysis : Presence of severe tremors, a significant drop in rectal temperature, signs of analgesia (loss of pain sensation), and noticeable lacrimation (tearing)

Related Products: Phenylephrine (HY-B0769)

Your information is safe with us.